Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting

ACS Nano

Volumn 7, Issue 12, 2013, Pages 10597-10611

  Ansar, Maria ^a   Serrano, Daniel ^a   Papademetriou, Iason ^b   Bhowmick, Tridib Kumar ^a   Muro, Silvia ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

carrier size; ceramide; clathrin associated receptors; ICAM 1 pathway; intracellular drug delivery; receptor mediated endocytosis; sphingomyelinase

Indexed keywords

CARRIER SIZE; CERAMIDE; CLATHRIN-ASSOCIATED RECEPTORS; ICAM-1 PATHWAY; INTRACELLULAR DRUG DELIVERY; RECEPTOR-MEDIATED ENDOCYTOSIS; SPHINGOMYELINASE;

CELL ADHESION; CELL CULTURE; CERAMIDES; DRUG DELIVERY; ENDOTHELIAL CELLS; ENZYME ACTIVITY; MOLECULAR BIOLOGY; PROTEINS;

CELL MEMBRANES;

ACTIN; CERAMIDE; CLATHRIN; DRUG CARRIER; ICAM1 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; POLYSTYRENE DERIVATIVE; SOMATOMEDIN B RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFERRIN RECEPTOR;

ANIMAL; ARTICLE; BINDING SITE; C57BL MOUSE; CAVEOLA; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PARTICLE SIZE; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; ANIMALS; BINDING SITES; CAVEOLAE; CELL MEMBRANE; CELL SURVIVAL; CERAMIDES; CLATHRIN; DRUG CARRIERS; ENDOCYTOSIS; ENDOSOMES; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, INBRED C57BL; PARTICLE SIZE; POLYSTYRENES; RECEPTOR, IGF TYPE 2; RECEPTORS, TRANSFERRIN; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84891364422     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn404719c     Document Type: Article

References (81)

1. Hoffman, A. S. The Origins and Evolution of "Controlled" Drug Delivery Systems J. Controlled Release 2008, 132, 153-163
2. Hans, M. L.; Lowman, A. M. Biodegradable Nanoparticles for Drug Delivery and Targeting Curr. Opin. Solid State Mater. Sci. 2002, 6, 319-327
3. Torchilin, V. P. Multifunctional Nanocarriers Adv. Drug Delivery Rev. 2006, 58, 1532-1555
4. Langer, R. Drug Delivery-Drugs on Target Science 2001, 293, 58-59
5. Debbage, P. Targeted Drugs and Nanomedicine. Present and Future Curr. Pharm. Des. 2009, 15, 153-172
6. Parveen, S.; Misra, R.; Sahoo, S. K. Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics, and Imaging Nanomedicine 2012, 8, 147-166
7. Muro, S. Challenges in Design and Characterization of Ligand-Targeted Drug Delivery Systems J. Controlled Release 2012, 164, 125-137
8. Conner, S. D.; Schmid, S. L. Regulated Portals of Entry into the Cell Nature 2003, 422, 37-44
9. Jones, A. T. Gateways and Tools for Drug Delivery: Endocytic Pathways and the Cellular Dynamics of Cell Penetrating Peptides Int. J. Pharm. 2008, 354, 34-38
10. Viera, O. V.; Botelho, R. J.; Grinstein, S. Phagosome Maturation: Aging Gracefully Biochem. J. 2002, 366, 689-704
11. Swanson, J. A.; Watts, C. Macropinocytosis Trends Cell Biol. 1995, 5, 424-428
12. Bareford, L. M.; Swaan, P. W. Endocytic Mechanism for Targeted Drug Delivery Adv. Drug Delivery Rev. 2007, 59, 748-758
13. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-Dependent Internalization of Particles via the Pathways Of Clathrin- and Caveolae-Mediated Endocytosis Biochem. J. 2004, 377, 159-169
14. Gratton, S. E. A.; Roff, P. A.; Pohlhaus, P. D.; Luft, C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The Effect of Particle Design on Cellular Internalization Pathways Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 11613-11618
15. Doshi, N.; Prabhakarpandian, B.; Rea-Ramsey, A.; Pant, K.; Sundaram, S.; Mitragotri, S. Flow and Adhesion of Drug Carriers in Blood Vessels Depend on Their Shape: A Study Using Model Synthetic Microvascular Networks J. Controlled Release 2010, 146, 196-200
16. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery Nat. Nanotechnol. 2007, 2, 249-255
17. Charoenphol, P.; Huang, R. B.; Eniola-Adefeso, O. Potential Role of Size and Hemodynamics in the Efficacy of Vascular-Targeted Spherical Drug Carriers Biomaterials 2010, 31, 1392-1402
18. Stan, R. V. Endocytosis Pathways in Endothelium: How Many? Am. J. Physiol.: Lung Cell Mol. Physiol. 2006, 290, 806-808
19. Atochina, E. N.; Balyasnikova, I. V.; Danilov, S. M.; Granger, D. N.; Fisher, A. B.; Muzykantov, V. R. Immunotargeting of Catalase to ACE or ICAM-1 Protects Perfused Rat Lungs against Oxidative Stress Am. J. Phsyiol. 1998, 275, 806-817
20. Muro, S.; Wiewrodt, R.; Thomas, A.; Koniaris, L.; Albelda, S. M.; Muzykantov, V. R.; Koval, M. A Novel Endocytic Pathway Induced by Clustering Endothelial ICAM-1 or PECAM-1 J. Cell Sci. 2003, 116, 1599-1609
21. Muro, S.; Gajewski, C.; Koval, M.; Muzykantov, V. R. ICAM-1 Recycling in Endothelial Cells: A Novel Pathway for Sustained Intracellular Delivery and Prolonged Effects of Drugs Blood 2005, 105, 650-658
22. Bloemen, P. G.; Henricks, P. A.; vanBloois, L.; van den Tweel, M. C.; Bloem, A. C.; Nijkamp, F. P.; Crommelin, D. J.; Storm, G. Adhesion Molecules: A New Target for Immunoliposome-Mediated Drug Delivery FEBS Lett. 1995, 357, 140-144
23. Villanueva, F. S.; Jankowski, R. J.; Klibanov, S.; Pina, M. L.; Alber, S. M.; Watkins, S. C.; Brandenburger, G. H.; Wagner, W. R. Microbubbles Targeted to Intercellular Adhesion Molecule-1 Bind to Activated Coronary Artery Endothelial Cells Circulation 1998, 98, 1-5
24. Chittasupho, C.; Xie, S. X.; Baoum, A.; Yakovleva, T.; Siahaan, T. J.; Berkland, C. J. ICAM-1 Targeting of Doxorubicin-Loaded PLGA Nanoparticles to Lung Epithelial Cells Eur. J. Pharm. Sci. 2009, 37, 141-150
25. Muzykantov, V. Targeting Drugs to Pulmonary Endothelium Expert Opin. Drug Delivery 2005, 2, 909-926
26. Ghafarrian, R.; Bhowmick, T.; Muro, S. Transport of Nanocarriers across Gastrointestinal Epithelial Cells by a New Transcellular Route Induced by Targeting ICAM-1 J. Controlled Release 2012, 163, 25-33
27. Bhowmick, T.; Berk, E.; Cui, X.; Muzykantov, V. R.; Muro, S. Effect of Flow on Endothelial Endocytosis of Nanocarriers Targeted to ICAM-1 J. Controlled Release 2012, 157, 485-492
28. Rothlein, R.; Dustin, M. L.; Marlin, S. D.; Springer, T. A. A Human Intercellular Adhesion Molecule (ICAM-1) Distinct from LFA-1 J. Immunol. 1986, 137, 1270-1274
29. Muro, S. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1. In Endothelial Biomedicine, 1 st ed.; Cambridge University Press: New York, 2007; pp 1058-1070.
30. Muro, S.; Garnacho, C.; Champion, J. A.; Leferovich, J.; Gajewski, C.; Schuchman, E. H.; Mitragotri, S.; Muzykantov, V. R. Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-Targeted Carriers Mol. Ther. 2008, 16, 1450-1458
31. Serrano, D.; Bhowmick, T.; Chadha, R.; Garnacho, C.; Muro, S. Intercellular Adhesion Molecule 1 Engagement Modulates Sphingomyelinase and Ceramide, Supporting Uptake of Drug Carriers by the Vascular Endothelium Arterioscler., Thromb., Vasc. Biol. 2012, 32, 1178-1185
32. + Exchanger Proteins Am. J. Physiol.: Lung Cell Mol. Physiol. 2006, 290, 809-817
33. Zeidan, Y. H.; Jenkins, R. W.; Hannun, Y. A. Remodeling of Cellular Cytoskeleton by the Acid Sphingomyelinase/Ceramide Pathway J. Cell Biol. 2008, 181, 335-350
34. Holopainen, J. M.; Subramanian, M.; Kinnunen, P. K. J. Sphingomyelinase Induces Lipid Microdomain Formation in a Fluid Phosphotidylcholine/sphingomyelin Membrane Biochemistry 1998, 37, 17562-17570
35. Holopainen, J. M.; Angelova, M. I.; Kinnuen, P. K. J. Vectorial Budding of Vesicles by Asymmetrical Enzymatic Formation of Ceramide in Giant Liposomes Biophys. J. 2000, 78, 830-838
36. Grassme, H.; Jendrossek, V.; Bock, J.; Riehle, A.; Gulbins, E. Ceramide-Rich Membrane Rafts Mediate CD40 Clustering J. Immunol. 2002, 168, 298-307
37. Zha, X.; Pierini, L. M.; Leopold, P. L.; Skiba, P. J.; Tabas, I.; Maxfield, F. R. Sphingomyelinase Treatment Induces ATP-Independent Endocytosis J. Cell Biol. 1998, 140, 39-47
38. Ruiz-Arguiello, M. B.; Goni, F. M.; Alonso, A. Vesicle Membrane Fusion Induced by the Concerted Activities of Sphingomyelinase and Phospholipase C J. Biol. Chem. 1998, 273, 22977-22982
39. Grassme, H.; Riethmuller, J.; Gulbins, E. Biological Aspects of Ceramide-Enriched Membrane Domains Prog. Lipid Res. 2007, 46, 161-170
40. Grassme, H.; Becker, K. A.; Zhang, Y.; Gulbins, E. Ceramide in Bacterial Infections and Cystic Fibrosis J. Biol. Chem. 2008, 389, 1371-1379
41. Dahms, N. M.; Olson, L. J.; Kim, J. P. Strategies for Carbohydrate Recognition by the Mannose 6-Phosphate Receptor Glycobiology 2008, 18, 664-678
42. Dautry-Varsat, A. Receptor-Mediated Endocytosis: The Intracellular Journey of Transferrin and Its Receptor Biochimie 1986, 68, 375-381
43. Korenfeld, S. Structure and Function of the Mannose 6-Phosphate/ Insulinlike Growth Factor II Receptors Annu. Rev. Biochem. 1992, 61, 307-330
44. Valentino, K.; Phan, H.; Ocrant, I.; Rosenfeld, R. G. Distribution of Insulin-Like Growth Factor II Receptor Immunoreactivity in Rat Tissues Endocrinology 1987, 122, 2753-2763
45. Taylor, J. E.; Scott, C. D.; Baxter, R. C. Comparison of Receptors for Insulin-Like Growth Factor II from Various Rat Tissues J. Endocrinol. 1987, 115, 35-41
46. Funk, B.; Kessler, U.; Eisenmenger, W.; Hansmann, A.; Kolb, H. J.; Kiess, W. Expression of the Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor in Multiple Human Tissues During Fetal Life and Early Infancy J. Clin. Endocrinol. Metab. 1992, 75, 424-431
47. Lee, J. S.; Weiss, J.; Martin, J. L.; Scott, C. D. Increased Expression of the Mannose 6-phosphate/Insulin-Like Growth Factor-II Receptor in Breast Cancer Cells Alters Tumorigenic Properties in Vitro and in Vivo Int. J. Cancer 2003, 107, 564-570
48. Wei, Y.; Li, J.; Huang, J.; Zhang, X.; Zhao, H.; Cui, C.; Li, Y.; Hu, S. Elevation of IGF-2 Receptor and the Possible Underlying Implications in End-Stage Heart Failure Patients before and after Heart Transplantation J. Cell. Mol. Med. 2012, 16, 1038-1046
49. Ajantsan, A. R.; Aoki, M.; Warita, H.; Ki, N. S. Z.; Itoyama, Y. T. Up-Regulation of Insulin-Like Growth Factor-II Receptor in Reactive Astrocytes in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Rats Tohoku J. Exp. Med. 2008, 214, 303-310
50. Gary-Bobo, M.; Nirde, P.; Jeanjean, A.; Morere, A.; Garcia, M. Mannose 6-Phosphate Receptor Targeting and Its Applications in Human Diseases Curr. Med. Chem. 2007, 14, 2945-2953
51. Prakash, J.; Beljaars, L.; Harapanahalli, A. K.; Zeinstra-Smith, M.; Jager-Krikken, A. D.; Hessing, M.; Steen, H.; Poelstra, K. Tumor-Targeted Intracellular Delivery of Anticancer Drugs through the Mannose-6-Phosphate/ Insulin-Like Growth Factor II Receptor Int. J. Cancer. 2010, 126, 1966-1981
52. Muro, S.; Dziubla, T.; Qiu, W.; Leferovich, J.; Cui, X.; Berk, E.; Muzykantov, V. R. Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 J. Pharmacol. Exp. Ther. 2006, 317, 1161-1169
53. Garnacho, C.; Shuvaev, V.; Thomas, A.; McKenna, L.; Sun, J.; Koval, M.; Albelda, S.; Muzykantov, V.; Muro, S. RhoA Activation and Actin Reorganization Involved in Endothelial CAM-mediated Endocytosis of Anti-PECAM Carriers: Critical Role for Tyrosine 686 in the Cytoplasmic Tail of PECAM-1 Blood 2008, 111, 3024-3033
54. Grau, G. E.; Lambert, P. H.; Vassalli, P.; Piguet, P. F. Tumor Necrosis Factor (TNF) and Pathology; Its Relationships with Other Cytokines Schweiz Med. Wochenschr. 1989, 119, 1756-1761
55. Garnacho, C.; Albelda, S. M.; Muzykantov, V. R.; Muro, S. Differential Intra-Endothelial Delivery of Polymer Nanocarriers Targeted to Distinct PECAM-1 Epitopes J. Controlled Release 2008, 130, 226-233
56. Shakor, A. B. A.; Atia, M. M.; Kwiatkowska, K.; Sobota, A. Cell Surface Ceramide Controls Translocation of Transferrin Receptor to Clathrin-Coated Pits Cell. Signalling 2012, 24, 677-684
57. Byrd, J. C.; MacDonald, R. G. Mechanisms for High Affinity Mannose 6-Phosphate Ligand Binding to the Insulin-Like Growth Factor II/Mannose 6-Phosphate Receptor J. Biol. Chem. 2000, 275, 18638-18646
58. Vyas, S. P.; Sihorkar, V. Endogenous Carriers and Ligands in Non-Immunogenic Site-Specific Drug Delivery Adv. Drug Delivery Rev. 2000, 43, 101-164
59. Shuvaev, V. V.; Illies, M. A.; Simone, E.; Zaitsev, S.; Kim, Y.; Cai, S.; Mahmud, A.; Dziubla, T.; Muro, S.; Discher, D. E. et al. Endothelial Targeting of Antibody-Decorated Polymeric Filomicelles ACS Nano 2011, 5, 6991-6999
60. Collins, A.; Warrington, A.; Taylor, K. A.; Svitkina, T. Structural Organization of the Actin Cytoskeleton at the Sites of Clathrin Mediated Endocytosis Curr. Biol. 2011, 21, 1167-1175
61. Kanzaki, M.; Pessin, J. E. Caveolin-Associated Filamentous Actin (Cav-actin) Defines a Novel F-actin Structure in Adipocytes J. Biol. Chem. 2002, 277, 25867-25869
62. Coppolino, M. G.; Krause, M.; Hagendorff, P.; Monner, D. A.; Trimble, W.; Grinstein, S.; Wehland, J.; Sechi, A. S. Evidence for a Molecular Complex Consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that Links the Actin Cytoskeleton to Fc Gamma Receptor Signalling During Phagocytosis J. Cell. Sci. 2001, 114, 4307-4318
63. Barreiro, O.; Yanez-Mo, M.; Serrador, J. M.; Montoya, M. C.; Vicente-Manzanares, M.; Tejedor, R.; Furthmayr, H.; Sanchez-Madrid, E. Dynamic Interaction of VCAM-1 and ICAM-1 with Moesin and Ezrin in a Novel Endothelial Docking Structure for Adherent Leukocytes J. Cell Biol. 2002, 157, 1233-1245
64. Serrano, D.; Muro, S. Endothelial Cell Adhesion Molecules and Drug Delivery Applications. In Mechanobiology of the Endothelium; Science Publishers: MD, 2013, in press.
65. Kolesnick, R.; Fuks, Z. Ceramide: A Signal for Apoptosis or Mitogenesis J. Exp. Med. 1995, 181, 1949-1952
66. Levade, T.; Jaffrezou, J. Signaling Sphingomyelinases: Which, Where, How and Why Biochim. Biophys. Acta 1999, 1438, 1-17
67. Morad, S. A.; Cabot, M. C. Ceramide-Orchestrated Signaling in Cancer Cells Nat. Rev. 2013, 13, 51-65
68. 2 Acts on Cellular Membranes To Generate Ceramide Signaling and Initiate Apoptosis in Tracheobronchial Epithelial Cells J. Cell Sci. 1998, 111, 3209-3220
69. Papademetriou, I. T.; Garnacho, C.; Schuchman, E. H.; Muro, S. In Vivo Performance of Polymer Nanocarriers Dually-Targeted to Epitopes of the Same or Different Receptors Biomaterials 2013, 34, 3459-3466
70. Pardridge, W. M. Biopharmaceutical Drug Targeting to the Brain J. Drug Targeting 2010, 18, 157-167
71. Muro, S. New Biotechnological and Nanomedicine Strategies for Treatment of Lysosomal Storage Disorders Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2010, 2, 189-204
72. Cardone, M.; Porto, C.; Tarallo, A.; Vicinanze, M.; Rossi, B.; Polishchuk, E.; Donaudy, F.; Andria, G.; Matteis, M.; Parenti, G. Abnormal Mannose-6-Phosphate Receptor Trafficking Impairs Recombinant Alpha-Glucosidase Uptake in Pompe Disease Fibroblasts Pathogenetics 2008, 1, 6
73. Dhami, R.; Schuchman, E. H. Mannose 6-Phosphate Receptor Mediated Uptake Is Defective in Acid Sphingomyelinase-Deficient Macrophages: Implications for Niemann-Pick Disease Enzyme Replacement Therapy J. Biol. Chem. 2004, 279, 1526-1532
74. Ravindran, S.; Snee, P. T.; Ramachandran, A.; George, A. Acidic Domain in Dentin Phosphophoryn Facilitates Cellular Uptake: Implications in Targeted Protein Delivery J. Biol. Chem. 2013, 288, 16098-16109
75. Boeneman, K.; Delehanty, J. B.; Blanco-Canosa, J. B.; Susumu, K.; Stewart, M. H.; Oh, E.; Huston, A. L.; Dawson, G.; Ingale, S.; Walters, R. et al. Selecting Improved Peptidyl Motifs for Cytosolic Delivery of Disparate Protein and Nanoparticle Materials ACS Nano 2013, 7, 3778-3796
76. Han, H.-S.; Martin, J. D.; Lee, J.; Harris, D. H.; Fukumura, D.; Jain, R. K.; Bawendi, M. Spatial Charge Configuration Regulates Nanoparticle Transport and Binding Behavior in Vivo Angew. Chem., Int. Ed. 2013, 52, 1414-1419
77. Henry, B.; Moller, C.; Dimanche-Boitrel, M. T.; Gulbins, E.; Becker, K. A. Targeting the Ceramide System in Cancer Cancer Lett. 2013, 332, 286-294
78. Kartal-Yandim, M.; Apohan, E.; Baran, Y. Therapeutic Potential of Targeting Ceramide/Glucosylceramide Pathway in Cancer Cancer Chemother. Pharmacol. 2013, 71, 13-20
79. Barth, B. M.; Cabot, M. C.; Kester, M. Ceramide-Based Therapeutics for the Treatment of Cancer Anticancer Agents Med. Chem. 2011, 11, 911-919
80. Zhang, P.; Liu, B.; Jenkins, G. M.; Hannun, Y. A.; Obeid, L. M. Expression of Neutral Sphingomyelinase Identifies a Distinct Pool of Sphingomyelin Involved in Apoptosis J. Biol. Chem. 1997, 272, 9609-9612
81. Wu, B. X.; Clarke, C. J.; Hannun, Y. A. Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses NeuroMol. Med. 2010, 12, 320-330